Ticker Launch

SPAC · Merger completed

Brookline Capital Acquisition Corp.

Business combination with Apexigen America, Inc.

Brookline Capital Acquisition Corp. is a blank-check company (SPAC) that raised $50M in its initial public offering on Jan 29, 2021. It completed its business combination with Apexigen America, Inc. on Jul 29, 2022; the combined company is Apexigen, Inc. (APGN). Ellenoff Grossman & Schole advised the SPAC and Graubard Miller advised the underwriters on the IPO.

Status
Merger completed
IPO date
Jan 29, 2021
IPO size
$50M
Target
Apexigen America, Inc. (Legacy Apexigen)
Announced
Mar 18, 2022
Closed
Jul 29, 2022
Combined company
Apexigen, Inc. (APGN)
SPAC counsel (IPO)
Ellenoff Grossman & Schole
Underwriters' counsel (IPO)
Graubard Miller

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2022